Presenting Kromasil EternityXT
AkzoNobel presents its latest preparative HPLC product, Kromasil EternityXT, an extension of the Eternity grafted technology platform, a material with an extended lifetime for preparative applications under extremely demanding conditions.
AkzoNobel presents its latest preparative HPLC product, Kromasil EternityXT, an extension of the Eternity grafted technology platform, a material with an extended lifetime for preparative applications under extremely demanding conditions.
Kromasil Eternity was introduced a few years ago, for analytical HPLC on smaller particle sizes. The new EternityXT product is based on a 10 µm Kromasil 100 Å silica matrix, well-known for its high mechanical stability and well-defined pore structure. An organosilane is immobilized on the silica and, under certain proprietary conditions, merged into an organic/inorganic interfacial gradient. The pore size is virtually unchanged. This process step is what gives Kromasil EternityXT its extreme chemical stability, extending the pH range that can normally be used with regular silica based HPLC media.
Finally, the product is functionalized with polymeric C18 followed by a proprietary endcapping process.
The pH window where EternityXT can be used is from 1 to 12, giving more flexibility than ever when optimizing for large-scale applications.
The superior chemical and mechanical stability lead to longer media lifetime. The improved chromatographic performance and better selectivity at high pH, leads to higher loadability, and improved productivity. A combination leading to reduced cost in the production!
Download the folder on www.kromasil.com/EternityXT
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
